Matthias Barton
#163,912
Most Influential Person Now
Researcher
Matthias Barton's AcademicInfluence.com Rankings
Matthias Bartoncomputer-science Degrees
Computer Science
#9662
World Rank
#10139
Historical Rank
Machine Learning
#4292
World Rank
#4341
Historical Rank
Artificial Intelligence
#4643
World Rank
#4705
Historical Rank
Database
#6627
World Rank
#6862
Historical Rank
Download Badge
Computer Science
Matthias Barton's Degrees
- Masters Artificial Intelligence Stanford University
Similar Degrees You Can Earn
Why Is Matthias Barton Influential?
(Suggest an Edit or Addition)Matthias Barton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The G-protein-coupled estrogen receptor GPER in health and disease (2011) (701)
- Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs (2000) (597)
- Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. (1998) (377)
- Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. (1997) (328)
- Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. (2009) (326)
- Estrogen biology: New insights into GPER function and clinical opportunities (2014) (319)
- Endothelin: 20 years from discovery to therapy. (2008) (302)
- Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. (1996) (297)
- Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors (2011) (257)
- Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. (1993) (249)
- Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. (1997) (245)
- Biology of the Endothelium (1997) (237)
- Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. (2005) (234)
- Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation (1997) (181)
- Endothelin and Endothelin Antagonists in Chronic Kidney Disease (2014) (181)
- Postmenopausal hypertension: mechanisms and therapy. (2009) (181)
- ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension (1998) (176)
- Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. (1997) (161)
- Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. (2006) (153)
- Role of Podocytes for Reversal of Glomerulosclerosis and Proteinuria in the Aging Kidney After Endothelin Inhibition (2004) (153)
- Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives (2018) (153)
- Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. (2009) (150)
- The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. (2011) (149)
- Differential Effects of 17&bgr;-Estradiol on Function and Expression of Estrogen Receptor &agr;, Estrogen Receptor &bgr;, and GPR30 in Arteries and Veins of Patients With Atherosclerosis (2007) (146)
- Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. (1997) (145)
- Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. (2000) (136)
- Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression (2002) (135)
- Non-genomic regulation of vascular cell function and growth by estrogen (2009) (126)
- Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients (2020) (124)
- G Protein-coupled Estrogen Receptor Protects from Atherosclerosis (2014) (124)
- Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade. (1997) (123)
- Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. (2003) (115)
- Position paper: The membrane estrogen receptor GPER – Clues and questions (2012) (111)
- Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. (2007) (108)
- Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis. (2000) (107)
- Endothelin: 30 Years From Discovery to Therapy. (2019) (105)
- Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis (2010) (104)
- Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function. (1998) (103)
- Reversal of proteinuric renal disease and the emerging role of endothelin (2008) (103)
- Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. (2001) (102)
- Cholesterol and atherosclerosis: modulation by oestrogen (2013) (99)
- Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction (2012) (96)
- Dilation of Epicardial Coronary Arteries by the G Protein-Coupled Estrogen Receptor Agonists G-1 and ICI 182,780 (2010) (94)
- ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. (1998) (93)
- Childhood obesity: a life-long health risk (2012) (92)
- Distinct Roles of Estrogen Receptors &agr; and &bgr; Mediating Acute Vasodilation of Epicardial Coronary Arteries (2007) (85)
- Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? (2012) (81)
- Emerging roles of GPER in diabetes and atherosclerosis (2015) (80)
- Endothelial‐derived superoxide anions in pig coronary arteries: evidence from lucigenin chemiluminescence and histochemical techniques. (1997) (79)
- Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. (2007) (71)
- Balloon Angioplasty – The Legacy of Andreas Grüntzig, M.D. (1939–1985) (2014) (70)
- The effect of age on the pharmacokinetics of diazepam. (1980) (70)
- Endothelin in Coronary Artery Disease and Myocardial Infarction (2013) (67)
- Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? (2001) (66)
- Native LDL Induces Proliferation of Human Vascular Smooth Muscle Cells via Redox-Mediated Activation of ERK 1/2 Mitogen-Activated Protein Kinases (2002) (66)
- Deletion of G Protein–Coupled Estrogen Receptor Increases Endothelial Vasoconstriction (2012) (64)
- Regulation of Vascular Smooth Muscle Tone by Adipose-Derived Contracting Factor (2013) (63)
- Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries. (1998) (63)
- Prevention and endothelial therapy of coronary artery disease. (2013) (63)
- Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries. (2007) (62)
- GPER regulates endothelin-dependent vascular tone and intracellular calcium. (2012) (62)
- Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics (2000) (57)
- Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth. (2003) (56)
- Activation of Pro‐Inflammatory and Anti‐Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling (2005) (54)
- Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. (2010) (53)
- Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? (2007) (53)
- ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. (2009) (53)
- Estrogens and Coronary Artery Disease: New Clinical Perspectives. (2016) (52)
- Obligatory role for GPER in cardiovascular aging and disease (2016) (52)
- Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER (2016) (50)
- Receptor‐ and non‐receptor‐mediated clearance of bigendothelin and endothelin‐1: differential effects of acute and chronic ETA receptor blockade (2000) (50)
- Deloading of the Left Ventricle by Ventricular Assist Device Normalizes Increased Expression of Endothelin ETA Receptors But Not Endothelin-Converting Enzyme-1 in Patients With End-Stage Heart Failure (2000) (49)
- Endothelium and Atherogenesis: Endothelial Therapy Revisited (2001) (49)
- Aging and endothelin: determinants of disease. (2014) (48)
- Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. (1999) (47)
- Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. (2002) (45)
- Endothelin, hypercholesterolemia and atherosclerosis. (2003) (43)
- Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. (2002) (43)
- Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice (2002) (43)
- Cardiovascular consequences of the obesity pandemic: need for action (2003) (41)
- Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy. (2016) (41)
- The therapeutic potential of endothelin receptor antagonists in cardiovascular disease (2001) (36)
- Endothelin and the podocyte (2012) (36)
- Fat intake and cardiovascular response (2008) (35)
- 17β-Estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries (1998) (35)
- Endothelin and the glomerulus in chronic kidney disease. (2015) (35)
- The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte. (2011) (35)
- Ageing as a determinant of renal and vascular disease: role of endothelial factors. (2005) (35)
- Endothelin antagonists for hypertension and renal disease. (1999) (34)
- Endothelin and podocyte injury in chronic kidney disease. (2011) (32)
- Contractile responses to histamine, serotonin, and angiotensin II are impaired by 17 beta-estradiol in human internal mammary arteries in vitro. (1997) (31)
- Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease. (2000) (31)
- Endothelin in atherosclerosis: importance of risk factors and therapeutic implications. (2000) (31)
- Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis. (2008) (30)
- Regional Heterogeneity of Functional Changes in Conduit Arteries After High‐fat Diet (2008) (30)
- Different vascular reactivity of human internal mammary and inferior epigastric arteries in vitro. (1993) (30)
- Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade. (1998) (29)
- Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-recep (1997) (29)
- G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. (2015) (28)
- Endothelial therapy of atherosclerosis and its risk factors. (2003) (28)
- Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells. (2005) (27)
- Transcriptional regulation of vascular bone morphogenetic protein by endothelin receptors in early autoimmune diabetes mellitus. (2006) (27)
- Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. (2002) (26)
- Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. (2005) (25)
- GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure. (2011) (23)
- Nicolaus Copernicus and the rapid vascular responses to aldosterone (2015) (22)
- Protective role of ETA endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats. (2004) (22)
- Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension (2017) (21)
- Endothelin antagonists in clinical trials: lessons learned. (2011) (21)
- In-vivo interaction of nitric oxide and endothelin. (2004) (21)
- Endothelin stimulates vascular hydroxyl radical formation: effect of obesity. (2007) (20)
- Mechanisms and therapy of atherosclerosis and its clinical complications. (2013) (20)
- Role of endothelin receptors for renal protection and survival in hypertension: waiting for clinical trials. (2006) (20)
- Recent developments on endothelin antagonists as immunomodulatory drugs--from infection to transplantation medicine. (2006) (19)
- Endothelin regulates angiotensin-converting enzyme in the mouse kidney. (2000) (19)
- Marked Heterogeneity of Endothelin-Mediated Contractility and Contraction Dynamics in Mouse Renal and Femoral Arteries (2006) (19)
- Role of endothelin during experimental Trypanosoma cruzi infection in rats. (2002) (19)
- Anatomically distinct activation of endothelin-3 and the L-arginine/nitric oxide pathway in the kidney with advanced aging. (2005) (18)
- Postural Effects on Interstitial Fluid Pressure in Humans (2006) (17)
- Estrogen Signaling in the Adrenal Cortex: Implications for Blood Pressure Sex Differences (2016) (17)
- Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral atherosclerosis. (2006) (17)
- Testosterone and secondary hypertension: new pieces to the puzzle. (2012) (17)
- Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? (2001) (17)
- Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries. (2014) (16)
- Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension (2017) (16)
- GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases (2018) (16)
- Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease (2007) (15)
- Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging. (2014) (15)
- GPER Mediates Functional Endothelial Aging in Renal Arteries (2017) (15)
- Endothelin: 20 years from discovery to therapy 1 (2008) (15)
- Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium. (2002) (14)
- Estrogen-independent activation of estrogen receptors. (2011) (14)
- Aging and biomedicine 2005: where should we go from here? (2005) (13)
- Early Aging and Anatomic Heterogeneity Determine Cyclooxygenase-mediated Vasoconstriction to Angiotensin II in Mice (2006) (13)
- 17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. (1998) (13)
- Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene. (1999) (12)
- Obesity and heterozygous endothelial overexpression of prepro-endothelin-1 modulate responsiveness of mouse main and segmental renal arteries to vasoconstrictor agents. (2014) (12)
- HuR-ry Up: How Hydrogen Sulfide Protects Against Atherosclerosis (2019) (12)
- Endothelial vasoconstrictor prostanoids, vascular reactivity, and acute renal failure. (1998) (11)
- The future of endothelin research: scientific mentoring and beyond. (2012) (11)
- Anti-Inflammatory Effects of Endothelin Receptor Antagonists and their Importance for Treating Human Disease (2010) (11)
- Oral contraceptives and the risk of thrombosis and atherosclerosis (2002) (11)
- Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. (2013) (11)
- Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin (1997) (11)
- Vascular effects of estrogens: rapid actions, novel mechanisms, and potential therapeutic implications. (1999) (11)
- Nox1 downregulators: A new class of therapeutics (2019) (11)
- The First Tomoh Masaki Award (2011). (2012) (9)
- GPER is required for the age-dependent upregulation of the myocardial endothelin system. (2016) (9)
- Inflammation and atherosclerosis. (2007) (9)
- Increased expression of endothelin-converting enzyme-1 in failing human myocardium. (2002) (9)
- Linking regulation of nitric oxide to endothelin-1: The Yin and Yang of vascular tone in the atherosclerotic plaque. (2019) (9)
- Endothelin in heart failure (1999) (9)
- Endothelin in renal physiology and disease (2011) (8)
- Upregulation of Vascular ETB Receptor Gene Expression after Chronic ETA Receptor Blockade in Prediabetic NOD Mice (2004) (8)
- Downregulation of Renal Endothelin-Converting Enzyme 2 Expression in Early Autoimmune Diabetes (2006) (8)
- Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges. (2021) (8)
- Acute effects of 17 beta-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins. (2002) (8)
- 25 years of endothelin research: the next generation. (2014) (8)
- Sex and NO--beyond regulation of vasomotor tone. (2000) (8)
- Upregulation of Endothelin Receptor B in Human Endothelial Cells by Low-Density Lipoproteins (2006) (8)
- Beneficial Cardiovascular Effects of Endothelin ETA Receptor Blockade in Established Long-Term Heart Failure After Myocardial Infarction (2006) (7)
- Upregulation of Endothelin Converting Enzyme-1 in Host Liver During Chronic Cardiac Allograft Rejection (2006) (7)
- Antioxidant Activity and Sex Differences of Acute Vascular Effects of Amiodarone in Advanced Atherosclerosis (2007) (7)
- Postmenopausal hormone-replacement therapy. (2002) (7)
- Exercise is Medicine - Key to Cardiovascular Disease and Diabetes Prevention. (2020) (7)
- Endothelin antagonism and reversal of proteinuric renal disease in humans. (2011) (7)
- Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme (1997) (6)
- [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications]. (1996) (6)
- ER a , ER b , and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis (2009) (6)
- Endothelin XII. (2012) (5)
- 17β-Oestradiol inhibits growth of human vascular smooth muscle: Similar effects in cells from females and males (1996) (5)
- Estrogen and vascular resistance (1999) (5)
- [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication]. (1997) (5)
- Heart Failure With Preserved Ejection Fraction in Women (2020) (5)
- Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging (2015) (5)
- Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis (2015) (4)
- The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011. (2012) (4)
- Estrogen and apoptosis in atherosclerosis (2002) (4)
- Endothelin receptor blockade and nitric oxide bioactivity. (2001) (4)
- Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide. (2007) (3)
- Primum Non Nocere: Why Calcitriol («Vitamin» D) Hormone Therapy Is Not a Magic Bullet (2019) (3)
- Estrogen inhibits endothelin production in human endothelial cells: evidence for NO-independent, estrogen receptor-mediated mechanisms and thrombin-mediated superoxide release (1998) (3)
- In Memoriam: Paul M. Vanhoutte (2019) (3)
- Amiodarone Acutely Inhibits Vascular Activity of Endothelin-Converting Enzymes (2004) (3)
- Advancing and Translating Knowledge in Vascular Medicine (2014) (3)
- P-590: Obesity regulates renal endothelin and endothelin ETA receptor expression in vivo. Differential effects of chronic ETA receptor blockade (2001) (3)
- Role of Perivascular Adipose Tissue for Sex Differences in Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD) (2021) (3)
- Getting radical about obesity: new links between fat and heart disease. (2009) (3)
- Hypertension, diabetes mellitus, hypercholesterolemia, and endothelin B receptor-mediated renal nitric oxide release. (2000) (3)
- Obesity causes lymphatic vascular injury: time for clinical translation (2016) (3)
- Abstract 446: Selective Activation of G-Protein-Coupled Estrogen Receptor GPR30 Inhibits Vasoconstriction and Induces Vascular Smooth Muscle Cell ERK1/2 Phosphorylation (2007) (3)
- Effects of obesity on mortality in patients with unstable angina or non-ST-elevation myocardial infarction. (2007) (2)
- Redox-Mediated Activation of ERK 1 / 2 Mitogen-Activated Protein Kinases Native LDL Induces Proliferation of Human Vascular Smooth Muscle Cells via (2002) (2)
- Re: 'Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three dimensional mapping' (Cardiovasc Res 2000;45:310-320). (2000) (2)
- Themed section: endothelin (2013) (2)
- In memoriam: Wolfgang Kiowski, M.D. (1949-2012)--pioneer in clinical endothelin research. (2014) (2)
- Early life stress determines insulin signalling in adulthood (2019) (1)
- Serum from Patients with Severe Alcoholic Liver Cirrhosis Inhibits Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells (2021) (1)
- [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate]. (2004) (1)
- Author response: Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients (2020) (1)
- Lung cancer and hormone replacement therapy (2010) (1)
- Aging selectively impairs contractions to endothelin-1 but not to angiotensin II in murine carotid arteries (2013) (1)
- Endothelin ETA Receptor Blockade With Darusentan Increases Sodium and Potassium Excretion in Aging Rats (2006) (1)
- Permissive Role of GPER for Arterial Hypertension. (2019) (1)
- Endothelin Receptor Antagonists in Cardiovascular Medicine: Challenges and Opportunities (2012) (1)
- Waiting for Clinical Trials Role of Endothelin Receptors for Renal Protection and Survival in Hypertension. (2006) (1)
- Abstract P261: GPER is Required for Age-dependent Albuminuria and Glomerulosclerosis: Evidence for its Role in Podocyte Injury and Mesangial Nox1 Regulation (2018) (1)
- WISDOM Trial, Postmenopausal Hormone Replacement and Cardiovascular Events: Why it is still not wise to use equine estrogens (2017) (1)
- GPER mediates the age-dependent upregulation of the myocardial endothelin system (2016) (0)
- Protease-activated receptors and EDHF: the icing on the cake? (2004) (0)
- Abstract P607: Deletion of GPER Protects from Age-related Renovascular Dysfunction and Tubulo-interstitial Injury (2015) (0)
- In Memoriam: Paul M. Vanhoutte. (2019) (0)
- and Matthias Kretzler for Clinical Trials Role of Endothelin Receptors for Renal Protection and Survival in Hypertension : Waiting (2006) (0)
- Endothelium and endothelin: regulators of arterial stiffness and fibrinolysis in ANCA-associated vasculitis. (2022) (0)
- Endothelin receptor blockade and nitric oxide bioactivity [Cardiovascular Research 2001;49:146–151] (2019) (0)
- Enzyme In Vivo : Evidence for a Regulatory Role of Endothelin Obesity Is Associated With Tissue-Specific Activation of Renal Angiotensin-Converting (2000) (0)
- Localized effect of vascular aging on NADPH oxidase-mediated contractions to endothelin (2013) (0)
- superoxide anions inpigcoronary arteries: evidence fromlucigenin chemiluminescence andhistochemical techniques (2011) (0)
- Rapid vasodilation to raloxifene: role of oestrogen receptors and off‐target effects (2017) (0)
- smooth muscle cells caused by aging and hypertension endothelial cells and prostanoid receptors in vascular Gene expression changes of prostanoid synthases in (2015) (0)
- Tomoh Masaki. (2020) (0)
- Acute inhibition but not chronic deficiency of G protein‐coupled estrogen receptor reduces bioactivity of nitric oxide (2012) (0)
- Update on Hypertension Management 2018 , 19 , nr . 67 ENDOTHELIAL FACTORS IN THE PATHOGENESIS AND TREATMENT OF CHRONIC KIDNEY DISEASE (2018) (0)
- [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estro (2004) (0)
- C URRENT OPINION Cholesterol and atherosclerosis: modulation by oestrogen (2013) (0)
- Signaling Gender Differences of Cardiovascular Disease : New Perspectives for Estrogen Receptor (2013) (0)
- Obesity, diabetes and cardiovascular risk: How to disrupt a vicious cycle (2021) (0)
- Steroid Hormones and Receptors in Health and Disease (2021) (0)
- Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging (2015) (0)
- Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy (2015) (0)
- Editorial Board (1991) (0)
- Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors (2022) (0)
- In the vasculature , ETA receptors predominantly mediate vasoconstriction and mitogenesis , whereas ETB receptors mediate mainly vasodilation and inhib (2015) (0)
- Matthias Barton , Elvira Haas and Indranil Bhattacharya Getting Radical About Obesity : New Links Between Fat and Heart Disease (2009) (0)
- P-2: Human vascular smooth muscle cell DNA synthesis stimulated by native low density lipoproteins involves redox-sensitive pathways. Inhibition by N-acetylcysteine and green tea constituents (2001) (0)
- 3.P.6 Rapid vascular of superoxide dismutase involve nitric oxide, Cu2+ and binding to endothelial cells (1997) (0)
- Endothelin is getting older: How aging links endothelin with disease (2013) (0)
- Endothelin antagonists for hypertension and renal disease (Review Article) (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Matthias Barton?
Matthias Barton is affiliated with the following schools:
